We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Be warned: online forum selection clauses may oblige you to litigate abroad
  • Gowling WLG
  • Canada
  • June 30 2015

The decision in Douez v. Facebook, Inc., provides some comfort to online businesses that rely upon forum selection clauses in their online contracts


Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case
  • Gowling WLG
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record


Apotex v Shire, motion to amend statement of defence, modafinil, August 19, 2010
  • Gowling WLG
  • Canada
  • September 21 2010

In an action brought by Apotex for damages pursuant to Section 8 of the PMNOC Regulations against Shire after an unsuccessful PMNOC proceeding brought by Shire, Shire moved to amend the statement of defence


Novopharm v Pfizer, motion for interim relief pending appeal, pregabalin, October 5, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

See the earlier decisions in this case in the May 2010 and July 2010 editions of this newsletter


Merck v Apotex, PMNOC proceedings, dorzolamide and timolol, October 22, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

Merck’s patent in this case (the ‘965 patent) covered the co-administration and co-formulation of dorzolamide and timolol (which was sold as COSOPT


Hospira v Eli Lilly, appeal of order for further and better production of documents, gemcitabine, October 26, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

Eli Lilly alleged that gemcitabine made in China and imported into Canada by Hospira infringes Eli Lilly's patent for an intermediate process step in the manufacture of gemcitabine


Merck v Apotex, PMNOC proceedings, dorzolamide, October 22, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

This proceeding for an order of prohibition was a companion case to the case described below


Apotex v. Janssen-Ortho, motion to vary order of Federal Court of Appeal, levofloxacin, August 20, 2010
  • Gowling WLG
  • Canada
  • September 21 2010

Apotex filed a Notice of Allegation alleging that a particular patent licensed by Janssen-Ortho was invalid and not infringed


Eli Lilly v Novopharm, motion for reconsideration of judgment of Federal Court of Appeal (“FCA”), olanzapine, September 7, 2010
  • Gowling WLG
  • Canada
  • September 21 2010

Novopharm moved for reconsideration of the FCA's judgment allowing Lilly's appeal of a Federal Court decision that impeached Lilly's patent


Purdue Pharma v Minister of Health, judicial review of decision of Office of Patented Medicines and Lliaison (“OPML”), TARGIN, July 8, 2010
  • Gowling WLG
  • Canada
  • August 26 2010

Purdue filed a New Drug Submission ("NDS") as part of its application for a notice of compliance ("NOC") to market and sell the drug TARGIN in Canada